semaglutide and alzheimer's disease Preventative tirzepatide treatment does not alter progression in the 5xFAD mouse model of disease Associations of semaglutide with first‐time

A clinical trial published in 2022 found that an older GLP-1 drug called exenatide also reduced drinking among those who had both alcohol use disorder and obesity

Regular monitoring and dose titration minimize adverse events with both options

Is it safe to stop GLP-1 medication cold turkey

Important safety considerations include risk of acute pancreatitis (seek urgent medical attention for severe, persistent abdominal pain), gallbladder disease, dehydration leading to acute kidney injury with severe gastrointestinal effects, and potential worsening of diabetic retinopathy, particularly with rapid improvement in blood glucose control

Jiao R, Lin C, Cai X, Wang J, Wang Y, Lv F, et al

FAQs of WEGOVY INJECTION 0.5 mg (Semaglutide): Q: How should WEGOVY INJECTION 0.5 mg be stored for optimal effectiveness